Elaine Warburton

CEO & Co-Founder
QuantuMDx

Internet of Life – Transforming Healthcare

Just as the internet has revolutionised how we share information, the Internet of Life will transform our healthcare systems globally. In response to the growing threat of emerging infections and drug resistant ‘superbugs’, QuantuMDx is digitizing biology to share pathogen data on a never-before-seen scale. This technology leap will enable healthcare workers to prevent pandemics via rapid identification of novel infections in the field, and will create a cloud-based monitoring system to map the global spread of disease and drug resistance.

Elaine is an entrepreneur with over 25 years’ healthcare and biotechnology experience. With an eclectic background in nursing, genetics, accounting and running hospitals, she currently heads up QuantuMDx Group, one of the most exciting biotechs to emerge onto the ‘precision medicine’ global stage, developing a low cost handheld molecular lab with inbuilt DNA sequencing to help address humanitarian health challenges in both developed and developing nations. The first assays to be commercialised later in 2015 are in infectious disease and drug resistance testing. Elaine was awarded an OBE in the 2014 Queen’s New Year Honours for services to Innovation in Healthcare.

Buttontwitter Buttonlinkedin

Connect

Be Sociable

  • Twitter
  • Facebook
  • Linkedin
  • Youtube
  • Flickr
  • Lanyrd
  • Instagram
  • Google plus
  • Medium